PNPLA3 and steatosis: Since PNPLA3 I148M interferes with hepatocellular lipid metabolism, we next evaluated whether the effect of PNPLA3 148M/M on FPR was influenced by steatosis severity and risk factors for derangement of hepatic lipid metabolism.